Malin Life Sciences Holdings Ltd, Ten Percent Owner Other at Poseida Therapeutics, Inc. (PSTX), bought 77,670 shares at $6.89 ($531K) on 2021-11-29, disclosed to the SEC on 2021-11-29.
Open-market purchase of $531k PSTX by Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.89 | 1,054 | $7K | 1.4% |
| 2 | $6.81 | 27,251 | $186K | 35.0% |
| 3 | $6.81 | 27,251 | $186K | 35.0% |
| 4 | $6.89 | 11,057 | $76K | 14.4% |
| 5 | $6.89 | 11,057 | $76K | 14.4% |
| Total | $6.83 avg | 77,670 |
| $531K |
| 100% |
| Filing → |
| PSTX | BUY | 2021-12-02 | $673K | — | Filing → |
| PSTX | BUY | 2021-11-23 | $363K | — | Filing → |
| PSTX | BUY | 2021-11-18 | $5.5M | — | Filing → |